Asahi Kasei Sells Daramic to Drive Portfolio Transformation

Asahi Kasei, a diversified global manufacturer operating across healthcare, homes, and material sectors, strategically divested Daramic—its lead battery separator business—to Kingswood Capital Management, LP. Hideyuki Yamagishi, Primary Executive Officer of Asahi Kasei Corporation and President of the Material Sector, emphasized, “As we enter a new era for our company, it is critical that we align our resources with areas that will drive future growth,” he said. “This divestiture represents a strategic step that allows Asahi Kasei to evolve its capabilities with high-potential initiatives, such as strengthening our electronics business and expanding our lithium-ion battery separator business in North America, both key drivers of profit growth.” Asahi Kasei originally acquired Daramic in August 2015 through its purchase of Polypore, gaining control of both the lead battery separator business and the Celgard dry-process lithium-ion separator portfolio.

Sharpening Focus on Lithium-Ion Technologies

Moving forward, Asahi Kasei will intensify its focus on the lithium-ion battery separator market. The company plans to strengthen its Hipore wet-process lithium-ion technology through targeted investments, particularly for automotive applications across North America, Japan, and Korea. This approach supports growing demand for electric vehicles and positions the company as a significant player in next-generation energy storage solutions.

Advancing the “Trailblaze Together” Management Plan

Under its three-year medium-term management plan, Trailblaze Together, Asahi Kasei continues to boost capital efficiency and accelerate earnings by converting earlier growth investments into measurable returns. As part of this strategy, the company is executing structural reforms that funnel resources toward its core growth pillars—pharmaceuticals, critical care, overseas homes, and electronics.

As per the press release, recent decisions such as exiting the methyl methacrylate (MMA) monomer and related businesses, along with expanding production capacity for Pimel photosensitive polyimide, underscore the company’s disciplined approach. These actions reinforce Asahi Kasei’s commitment to long-term, sustainable, and profitable growth.